Article

AMGA Statement on 2022 Medicare Advantage Advance Notice

AMGA recommended that the Centers for Medicare & Medicaid Services (CMS) finalize a number of its proposed policies for the Medicare Advantage program.

Alexandria, VA – AMGA today recommended that the Centers for Medicare & Medicaid Services (CMS) finalize a number of its proposed policies for the Medicare Advantage program. AMGA and its members are strong supporters of the MA program, which offers a financing mechanism and benefit package that helps support care coordination.

AMGA also recommended that CMS continue to recognize the effect of COVID-19 and ensure that audio-only visits remain available for providers and their patients. CMS should allow audio-only telephone calls to satisfy the face-to-face requirement for collecting diagnosis information for risk adjustment purposes.

Read the full press release here.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
David Awad, PharmD, BCOP
Andrew Kuykendall, MD, Moffitt Cancer Center
Merrill H. Stewart, MD
Dr Margrit Wiesendanger
David Awad, PharmD, BCOP
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Dr Margrit Wiesendanger
Ibrahim Aldoss, MD, associate professor, City of Hope
Manmeet Ahluwalia, MD, MBA, FASCO, chief of medical oncology, chief scientific officer, and deputy director of the Miami Cancer Institute of Baptist Health South Florida
Cathy Eng, MD, FACP, FASCO
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo